AChE

Cat. No.

A95725

CAS No.

2409077-01-4

(-)-Mornaphthoate B

(-)-Mornaphthoate B is a methyl 2-naphthoate derivative isolated from the roots of Morinda officinalis var. officinalis. This compound does not exhibit inhibitory activity against acetylcholinesterase or butyrylcholinesterase. (-)-Mornaphthoate B serves as a valuable tool in cancer research, particularly in studies focused on non-small cell lung cancer and triple-negative breast cancer, contributing to understanding therapeutic strategies and mechanisms of action in these malignancies.

Cat. No.

A95826

CAS No.

30558-43-1

Oximino oxamyl

Synonyms: Oxamyl oxime

Oximino oxamyl is a drug derivative known for its inhibitory action on acetylcholinesterase. This compound exhibits significant biological activity, making it useful in pharmacological studies focused on neurodegenerative diseases and pesticide resistance research. Its application extends to evaluating enzyme inhibition mechanisms and developing innovative therapeutic strategies.

Cat. No.

A96284

CAS No.

2409077-00-3

(+)-Mornaphthoate B (d-Mornaphthoate B)

Synonyms: d-Mornaphthoate B

(+)-Mornaphthoate B is a methyl 2-naphthoate derivative isolated from the roots of Morinda officinalis var. officinalis. This compound has been shown to lack activity against acetylcholinesterase and butyrylcholinesterase. Its unique chemical structure and biological properties make (+)-Mornaphthoate B a potential candidate for research applications focused on non-small cell lung cancer and triple-negative breast cancer.

Cat. No.

A96579

CAS No.

2409077-05-8

(-)-Mornaphthoate D

(-)-Mornaphthoate D is a methyl 2-naphthoate derivative that targets various biological pathways. Isolated from the roots of Morinda officinalis var. officinalis, this compound demonstrates no inhibitory activity against acetylcholinesterase or butyrylcholinesterase. Its unique properties make it pertinent for research in non-small cell lung cancer and triple-negative breast cancer, contributing to the exploration of potential therapeutic strategies in oncology.

Cat. No.

A96594

CAS No.

2409077-02-5

(+)-Mornaphthoate C

(+)-Mornaphthoate C is a methyl 2-naphthoate derivative primarily investigated for its potential therapeutic applications. Derived from the roots of Morinda officinalis var. officinalis, this compound has demonstrated negligible activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) at a concentration of 50 μM. Additionally, (+)-Mornaphthoate C exhibits minimal cytotoxicity towards various cancer cell lines, making it a compound of interest in drug development research.

Cat. No.

A97141

CAS No.

30614-22-3

Pirimicarb-desmethyl

Pirimicarb-desmethyl is a key metabolite of the carbamate insecticide pirimicarb, functioning primarily through the inhibition of acetylcholinesterase activity. This compound offers valuable insights into the metabolic pathways of pirimicarb and can be used to study its environmental persistence and toxicological effects. Its application is important in both agricultural research and the assessment of pesticide safety.

Cat. No.

A97161

CAS No.

923571-15-7

Donepezil impurity 10

Donepezil impurity 10 is a known impurity associated with the compound Donepezil, a reversible inhibitor of the enzyme acetylcholinesterase. This reagent is significant for analytical studies aimed at monitoring the purity of Donepezil in pharmaceutical formulations. It serves as a reference standard in quality control processes and method development, ensuring compliance with regulatory guidelines in drug manufacturing and research applications.

Cat. No.

A98140

CAS No.

586-37-8

Rivastigmine impurity 12

Synonyms: m-Methoxyacetophenone

Rivastigmine impurity 12 (m-Methoxyacetophenone) is a known impurity associated with Rivastigmine, an acetylcholinesterase inhibitor used in the treatment of Alzheimer's disease. This compound serves as a valuable reference material for analytical chemistry applications, particularly in the development and validation of analytical methods for drug quality control. Its characterization contributes to ensuring the safety and efficacy of pharmaceutical formulations containing Rivastigmine.

Cat. No.

A98595

CAS No.

22065-85-6

Donepezil impurity 15

Donepezil impurity 15 is a chemical impurity associated with Donepezil, a reversible inhibitor of acetylcholinesterase. This impurity can serve as a reference standard in analytical and quality control laboratories for the characterization of Donepezil formulations. Research applications include stability testing, impurity profile assessments, and compliance with regulatory requirements in drug development.

Cat. No.

A98630

CAS No.

2107-69-9

5,6-Dimethoxyindan-1-one

Synonyms: 5,6-Dimethoxyindanone

5,6-Dimethoxyindan-1-one is a versatile drug intermediate employed in the synthesis of diverse active pharmaceutical ingredients. It has applications in the development of antiviral compounds and acetylcholinesterase butyrylcholinesterase inhibitors. This reagent serves as a critical building block in medicinal chemistry, facilitating the exploration of new therapeutic agents.

Cat. No.

A98735

CAS No.

888325-29-9

4-Hydroxy-3,3-dimethylcyclohexanone

4-Hydroxy-3,3-dimethylcyclohexanone serves as a crucial intermediate in the synthesis of human acetylcholinesterase (hAChE) inhibitors. Its role in the development of hAChE inhibitors makes it significant for research in neuropharmacology and disease models related to cholinergic dysfunction. This compound's unique structural properties facilitate the exploration of therapeutic agents targeting cognitive disorders.

Cat. No.

A98944

CAS No.

844694-83-3

Donepezil impurity 6

Donepezil impurity 6 is a known impurity associated with the cholinesterase inhibitor Donepezil. Its presence is significant for quality control and regulatory compliance in pharmaceutical formulations. This compound can be utilized in research to study the by-products and degradants of Donepezil, aiding in the development of more refined synthetic pathways and enhancing the understanding of drug stability and efficacy.

Cat. No.

A99179

CAS No.

1230021-34-7

Rivastigmine impurity 2

Synonyms: Diethyl rivastigmine

Rivastigmine impurity 2 is a known impurity associated with Rivastigmine, a reversible inhibitor of acetylcholinesterase. This compound can be utilized for analytical research and quality control studies in the pharmaceutical industry. Its characterization is essential for the assessment of drug purity and stability in formulations containing Rivastigmine.

Cat. No.

A99233

CAS No.

3063998-82-0

Rivastigmine impurity 8

Rivastigmine impurity 8 is a chemical impurity associated with the cholinesterase inhibitor rivastigmine. This impurity serves as a reference standard for quality control and analytical applications in pharmaceutical research. It facilitates the identification and quantification of impurities in drug formulations, contributing to the assessment of drug purity and safety in clinical and preclinical studies.

Cat. No.

A99323

CAS No.

4803-57-0

Donepezil impurity 21

Donepezil impurity 21 is a known impurity of the cognitive-enhancing agent Donepezil, which primarily targets acetylcholinesterase to enhance cholinergic neurotransmission. This compound is essential for the analysis of Donepezil formulations, particularly in the context of pharmaceutical quality control and regulatory compliance. Its characterization aids in understanding the stability and purity of Donepezil, supporting ongoing research in neurodegenerative disease therapies.

Cat. No.

A99343

CAS No.

1346242-32-7

Rivastigmine impurity 7

Rivastigmine impurity 7 is a recognized impurity derived from Rivastigmine, a reversible inhibitor of the enzyme acetylcholinesterase. This compound is primarily utilized in pharmaceutical research to study the purity and stability of Rivastigmine formulations. Its presence is critical in ensuring the quality and efficacy of cholinesterase inhibitors for therapeutic applications, particularly in the treatment of Alzheimer's disease.

Cat. No.

A99526

CAS No.

877606-65-0

Donepezil impurity 12

Donepezil impurity 12 is a known impurity of the acetylcholinesterase inhibitor Donepezil. This compound is utilized primarily in pharmacological research for analytical purposes, such as assessing the quality and purity of Donepezil formulations. Its characterization aids in understanding the stability and safety profiles of Donepezil-based therapies.

Cat. No.

A99911

CAS No.

855300-09-3

Rivastigmine impurity 10

Rivastigmine impurity 10 is a chemical impurity associated with the acetylcholinesterase inhibitor, Rivastigmine. This compound is primarily used for quality control and analytical purposes in pharmaceutical research. It is important for assessing the purity of Rivastigmine in formulations and ensuring compliance with regulatory standards.

Cat. No.

B10051

CAS No.

220170-71-8

Donepezil impurity 16

Donepezil impurity 16 is a known impurity of the cholinesterase inhibitor Donepezil, primarily targeting acetylcholinesterase. This compound is utilized in research to ensure the quality and consistency of Donepezil formulations. Its analysis is critical for assessing drug safety and efficacy in pharmaceutical development.

Cat. No.

B10084

CAS No.

25081-93-0

Rivastigmine impurity 3

Synonyms: Rivastigmine impurity B

Rivastigmine impurity 3 is a known impurity of the acetylcholinesterase inhibitor, Rivastigmine. This compound is utilized in quality control and analytical chemistry to assess the purity of Rivastigmine formulations. Its presence can significantly impact the safety and efficacy profiles of pharmaceutical products, making it relevant for regulatory compliance and drug development studies.

Cat. No.

B10091

CAS No.

1034439-43-4

Donepezil impurity 6 hydrochloride

Donepezil impurity 6 hydrochloride is a known impurity of the acetylcholinesterase inhibitor Donepezil hydrochloride. This compound is critical in the analysis of drug purity and assists in the characterization of donepezil formulations during research and development. Its presence is essential for quality control and safety assessments in the pharmaceutical industry.

Cat. No.

B10170

CAS No.

23308-82-9

Rivastigmine impurity 11

Rivastigmine impurity 11 is a known impurity of Rivastigmine, a reversible inhibitor of acetylcholinesterase. This compound is of significant interest for quality control and toxicological studies in pharmaceutical research. Its analysis is crucial for ensuring the purity and safety of Rivastigmine formulations, supporting compliance with regulatory standards in drug development.

Cat. No.

B10381

CAS No.

197010-22-3

Donepezil impurity 13

Donepezil impurity 13 is a chemical impurity associated with Donepezil, a reversible inhibitor of acetylcholinesterase. It serves as an important reference standard in analytical chemistry for the assessment of pharmaceutical purity. This compound is utilized in the quality control and stability testing of Donepezil formulations, ensuring compliance with regulatory standards in drug development and manufacturing processes.

Cat. No.

B10402

CAS No.

889443-69-0

Rivastigmine impurity 5

Synonyms: Rivastigmine impurity F

Rivastigmine impurity 5 is a designated impurity associated with the cholinesterase inhibitor Rivastigmine. This compound serves as a critical reference standard for quality control and analytical chemistry in pharmaceutical research. Its analysis is essential for ensuring the purity of Rivastigmine formulations, thereby supporting regulatory compliance and safety assessments in drug development.

Cat. No.

B10434

CAS No.

923035-05-6

Rivastigmine impurity 4

Synonyms: Rivastigmine impurity E

Rivastigmine impurity 4 is a chemical impurity associated with Rivastigmine, a reversible inhibitor of acetylcholinesterase. This impurity is relevant in the quality control and analytical evaluation of Rivastigmine formulations. Research applications include pharmacokinetic studies and the assessment of drug stability.